Prevention of hypoglycemia-induced neuronal death by minocycline

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Won, Seok J ^a   Kim, Jin H ^d   Yoo, Byung H ^a,b   Sohn, Min ^c   Kauppinen, Tiina M ^a   Park, Man Seong ^d   Kwon, Hyung Joo ^d   Liu, Jialing ^a   Suh, Sang W ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Inje University College of Medicine   (South Korea)

^c Inha University   (South Korea)

^d Hallym University   (South Korea)

Author keywords

Hypoglycemia; Microglia; Minocycline; Neuronal death

Indexed keywords

INSULIN; MINOCYCLINE; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL ACTIVATION; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DISEASE SEVERITY; GLUCOSE REPERFUSION; HIPPOCAMPAL CA1 REGION; HISTOLOGY; HYPERACTIVITY; HYPOGLYCEMIA; IMMUNOREACTIVITY; LONG TERM CARE; MALE; MENTAL PERFORMANCE; MICROGLIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION; THERAPY DELAY; TREATMENT RESPONSE;

EID: 84866502662     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-225     Document Type: Article

References (55)

1. Davis EA, Jones TW. Hypoglycemia in children with diabetes: incidence, counterregulation and cognitive dysfunction. J Pediatr Endocrinol Metab 1998, 11(Suppl 1):177-182.
2. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999, 159:281-284. 10.1001/archinte.159.3.281, 9989540.
3. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004, 350:2272-2279. 10.1056/NEJMra031354, 15163777.
4. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol 1985, 17:421-430. 10.1002/ana.410170502, 4004166.
5. Golden MP, Ingersoll GM, Brack CJ, Russell BA, Wright JC, Huberty TJ. Longitudinal relationship of asymptomatic hypoglycemia to cognitive function in IDDM. Diabetes Care 1989, 12:89-93. 10.2337/diacare.12.2.89, 2702906.
6. Ryan CM, Atchison J, Puczynski S, Puczynski M, Arslanian S, Becker D. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J Pediatr 1990, 117:32-38. 10.1016/S0022-3476(05)82440-0, 2196358.
7. Cryer PE. Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 2001, 281:E1115-E1121.
8. Kalimo H, Olsson Y. Effects of severe hypoglycemia on the human brain. Neuropathological case reports. Acta Neurol Scand 1980, 62:345-356.
9. Langan SJ, Deary IJ, Hepburn DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 1991, 34:337-344. 10.1007/BF00405006, 1864488.
10. Wieloch T. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D- aspartate antagonist. Science 1985, 230:681-683. 10.1126/science.2996146, 2996146.
11. Suh SW, Garnier P, Aoyama K, Chen Y, Swanson RA. Zinc release contributes to hypoglycemia-induced neuronal death. Neurobiol Dis 2004, 16:538-545. 10.1016/j.nbd.2004.04.017, 15262265.
12. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007, 117:910-918. 10.1172/JCI30077, 1838937, 17404617.
13. Moller JC, Klein MA, Haas S, Jones LL, Kreutzberg GW, Raivich G. Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia 1996, 17:121-132. 10.1002/(SICI)1098-1136(199606)17:2<121::AID-GLIA4>3.0.CO;2-5, 8776579.
14. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 2005, 37:17-21. 10.1016/j.biocel.2004.06.010, 15381143.
15. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010, 87:779-789. 10.1189/jlb.1109766, 2858674, 20130219.
16. Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 2006, 97:1314-1326. 10.1111/j.1471-4159.2006.03799.x, 16638021.
17. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007, 184:53-68. 10.1016/j.jneuroim.2006.11.014, 1868538, 17188755.
18. Shin BS, Won SJ, Yoo BH, Kauppinen TM, Suh SW. Prevention of hypoglycemia-induced neuronal death by hypothermia. J Cereb Blood Flow Metab 2010, 30:390-402. 10.1038/jcbfm.2009.229, 2949122, 19861976.
19. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 2001, 98:1466914674.
20. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000, 6:797-801. 10.1038/77528, 10888929.
21. Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, McLarnon JG. Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 2004, 48:85-90. 10.1002/glia.20051, 15326618.
22. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998, 95:15769-15774. 10.1073/pnas.95.26.15769, 28119, 9861045.
23. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999, 96:13496-13500. 10.1073/pnas.96.23.13496, 23976, 10557349.
24. Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, Oh YJ, Markelonis GJ, Oh TH. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 2003, 20:1017-1027. 10.1089/089771503770195867, 14588118.
25. Auer RN, Olsson Y, Siesjo BK. Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes 1984, 33:1090-1098. 10.2337/diabetes.33.11.1090, 6500189.
26. Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 2003, 23:10681-10690.
27. Schmued LC, Hopkins KJ, Fluoro-Jade B. A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000, 874:123-130. 10.1016/S0006-8993(00)02513-0, 10960596.
28. Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA. Zinc triggers microglial activation. J Neurosci 2008, 28:5827-5835. 10.1523/JNEUROSCI.1236-08.2008, 2680357, 18509044.
29. Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 1979, 93:74-104.
30. Biagas KV, Uhl MW, Schiding JK, Nemoto EM, Kochanek PM. Assessment of posttraumatic polymorphonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment. J Neurotrauma 1992, 9:363-371. 10.1089/neu.1992.9.363, 1337917.
31. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994, 25:1469-1475. 10.1161/01.STR.25.7.1469, 8023364.
32. Auer RN, Siesjo BK. Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab 1993, 7:611-625. 10.1016/S0950-351X(05)80210-1, 8379907.
33. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007, 55:1280-1286. 10.1002/glia.20440, 17659530.
34. Dereski MO, Chopp M, Knight RA, Rodolosi LC, Garcia JH. The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol 1993, 85:327-333.
35. Auer RN, Kalimo H, Olsson Y, Siesjo BK. The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex. Acta Neuropathol 1985, 67:13-24. 10.1007/BF00688120, 4024866.
36. Feuerstein GZ, Wang X, Barone FC. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann NY Acad Sci 1997, 825:179-193. 10.1111/j.1749-6632.1997.tb48428.x, 9369986.
37. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997, 17:9157-9164.
38. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997, 17:2746-2755.
39. Suh SW, Hamby AM, Gum ET, Shin BS, Won SJ, Sheline CT, Chan PH, Swanson RA. Sequential release of nitric oxide, zinc, and superoxide in hypoglycemic neuronal death. J Cereb Blood Flow Metab 2008, 28:1697-1706. 10.1038/jcbfm.2008.61, 18545258.
40. Scholz M, Cinatl J, Schadel-Hopfner M, Windolf J. Neutrophils and the blood-brain barrier dysfunction after trauma. Med Res Rev 2007, 27:401-416. 10.1002/med.20064, 16758487.
41. Takizawa S, Aratani Y, Fukuyama N, Maeda N, Hirabayashi H, Koyama H, Shinohara Y, Nakazawa H. Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain. J Cereb Blood Flow Metab 2002, 22:50-54.
42. Johnson EA, Dao TL, Guignet MA, Geddes CE, Koemeter-Cox AI, Kan RK. Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J Neuroinflammation 2011, 8:41-50. 10.1186/1742-2094-8-41, 3104356, 21535896.
43. Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC. Minocycline for short-term neuroprotection. Pharmacotherapy 2006, 26:515-521. 10.1592/phco.26.4.515, 3171989, 16553511.
44. Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, Yong VW, Patten SB, Duquette P, Antel JP, Mitchell JR. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2004, 55:756. 10.1002/ana.20111, 15122721.
45. Keck T, Balcom JH, Fernandez-del Castillo C, Antoniu BA, Warshaw AL. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002, 122:188-201. 10.1053/gast.2002.30348, 11781293.
46. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002, 125:1297-1308. 10.1093/brain/awf133, 12023318.
47. Zemke D, Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 2004, 27:293-298. 10.1097/01.wnf.0000150867.98887.3e, 15613934.
48. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007, 69:1404-1410. 10.1212/01.wnl.0000277487.04281.db, 17909152.
49. Rovet J, Alvarez M. Attentional functioning in children and adolescents with IDDM. Diabetes Care 1997, 20:803-810. 10.2337/diacare.20.5.803, 9135946.
50. Hershey T, Perantie DC, Warren SL, Zimmerman EC, Sadler M, White NH. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care 2005, 28:2372-2377. 10.2337/diacare.28.10.2372, 16186265.
51. Ennis K, Tran PV, Seaquist ER, Rao R. Postnatal age influences hypoglycemia-induced neuronal injury in the rat brain. Brain Res 2008, 1224:119-126. 2584018, 18582442.
52. Liu Z, Fan Y, Won SJ, Neumann M, Hu D, Zhou L, Weinstein PR, Liu J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007, 38:146-152. 10.1161/STROKEAHA.107.492785, 17122429.
53. Fan R, Xu F, Previti ML, Davis J, Grande AM, Robinson JK, Van Nostrand WE. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 2007, 27:3057-3063. 10.1523/JNEUROSCI.4371-06.2007, 17376966.
54. Hunter CL, Bachman D, Granholm AC. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann Neurol 2004, 56:675-688. 10.1002/ana.20250, 15468085.
55. Mizoguchi H, Takuma K, Fukakusa A, Ito Y, Nakatani A, Ibi D, Kim HC, Yamada K. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl) 2008, 196:233-241.